1. 704 Preclinical mechanism of action and pharmacodynamic biomarker studies of DuoBody®-CD3x5T4 in vitro and in vivo in solid cancer models. (9th November 2020) Authors: Kemper, Kristel; Gielen, Ellis; Houtkamp, Mischa; Boross, Peter; Burm, Saskia; Poot, Stefanie De; Engelberts, Patrick; Goeij, Bart de; Satijn, David; Sasser, Kate; Breij, Esther Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A746 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 704 Preclinical mechanism of action and pharmacodynamic biomarker studies of DuoBody®-CD3x5T4 in vitro and in vivo in solid cancer models. (9th November 2020) Authors: Kemper, Kristel; Gielen, Ellis; Houtkamp, Mischa; Boross, Peter; Burm, Saskia; Poot, Stefanie De; Engelberts, Patrick; Goeij, Bart de; Satijn, David; Sasser, Kate; Breij, Esther Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A423 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗